Drug Discovery & Trials

Targets, biomarkers, AI discovery, and Phases I–III clinical results.

  • 19 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Drug Discovery & Trials


newswise.com > articles > ua-little-rock-researcher-receives-grant-to-develop-more-realistic-model-of-human-intestine

UA Little Rock Researcher Receives Grant to Develop More Realistic Model of Human Intestine

3+ hour, 37+ min ago   (788+ words) Recreating the intricate structure of the human intestine in a laboratory could give scientists a better way to study disease and potential treatments — while reducing their reliance on animal experiments in the process. With support from a $72,419 grant, University of…...


aol.com > articles > aptar-pharma-massachusetts-general-hospital-210000000.html

Aptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery - AOL

2+ hour, 42+ min ago   (184+ words) AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that it has signed an agreement for a research collaboration led by Alice Stanton, PhD from Massachusetts General Hospital (MGH)…...


eagletribune.com > region > aptar-pharma-and-massachusetts-general-hospital-collaborate-on-platform-to-establish-predictive-data-driven-model > article_15b6138a-3db2-5bb5-931c-d664e63deb7b.html

Aptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery

2+ hour, 42+ min ago   (231+ words) Eagle-Tribune Aptar and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Sep 14, 2026-- AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer…...


biospace.com > employer-resources > report-the-insiders-guide-to-thought-leadership-in-biopharma

Report: The Insider's Guide to Thought Leadership in Biopharma

2+ hour, 10+ min ago   (175+ words) Report: The Insider’s Guide to Thought Leadership in Biopharma BioSpace This guide explores the evolving role of podcasts, webinars, and thought leadership programs in biopharma and provides practical recommendations for public relations agencies, corporate communications teams, and commercial marketers looking…...


asianbusinessreview.com > commentary > eastward-shift-in-biotech-world-why-india-and-china-could-lead-next-wave

The eastward shift in the biotech world: Why India and China could lead the next wave

22+ hour, 42+ min ago   (747+ words) China’s advantage is scale across discovery and development, and India in cost-efficiency and innovation footprint. For decades, the global biotechnology map was largely defined by a handful of established centres in the United States, and Europe. Boston, the Bay Area,…...


mbiz.heraldcorp.com > article > 10871987

KAIST cracks the code of RNA delivery in brain cells, opening new path for neurological treatment

1+ day, 8+ min ago   (490+ words) - Chemical tag m6A acts as a 'delivery label,' guiding RNA to the far ends of neurons - Study reveals new transport function of YTHDF2, previously known only as an RNA-degrading protein - Findings expected to shed light on RNA delivery errors behind neurodevelopmental and…...


miragenews.com > kaist-team-reveals-neuron-rna-delivery-mechanism-1743373

KAIST Team Reveals Neuron RNA Delivery Mechanism

21+ hour, 36+ min ago   (769+ words) < (From left) Bonsang Koo, Huiseon Hwang, and Minyeong Park, students in the Department of Biological Sciences, and Professor Ki-Jun Yoon > Much like a courier reading an address on a package, neurons must deliver RNA to the precise locations where it is needed. A KAIST research team has discovered how a small chemical modification on RNA acts as a "delivery tag,…...


en.sedaily.com > technology > 09/14/2026 > huons-wins-three-state-drug-development-grants-with-biotech

Huons Wins Three State Drug Development Grants With Biotech Partners

22+ hour, 23+ min ago   (339+ words) Joint Projects With SurgeneX, PinotBio and PulseInMyEars Programs Span mRNA Eye Drops, ADC and Peptide Cancer Drug Huons is moving to develop drug candidates across three different modalities — an mRNA eye drop, an antibody-drug conjugate (ADC) and a peptide cancer…...


eu.36kr.com > en > p > 3981789068065544

AI-Driven Pharmaceutical R&D Infrastructure Competition: Key Trends, Strategies & Industry Impact

22+ hour, 30+ min ago   (980+ words) When AI pushes drug design to the "minute-level", laboratories capable of validating such outputs are equally scarce. Swiss startup Adaptyv Bio completed wet experimental validation of 1320 protein sequences for Anthropic's Claude. Its revenue has increased nearly 10 times in the past…...